Reduce CVD Risk in Diabetes - Applying New Data to Clinical Practice: Mark Stolar, MD
In this episode, host Dr. Gregg Sherman and NACE expert faculty member, Dr. Mark Stolar, discuss applying recent clinical study results and new CVD risk reduction data to daily clinical practice, including patient management strategies, treatment selection considerations, and current and emerging treatments.About Mark Stolar, MD Mark Stolar, MD, is Associate Professor of Clinical Medicine, General Internal Medicine, and Geriatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. Stolar received his medical degree from the University of Illinois, Chicago. He completed his fellowship in Endocrinology at the Northwestern University Medical School and his residency in internal medicine at Lutheran General Hospital. Dr. Stolar is board certified in endocrinology, diabetes, and metabolism, and internal medicine. Dr. Stolar’s academic interests include diabetes, lipid disorders, and thyroid disease. A highly regarded speaker, he is actively involved in physician education in the area of diabetes and CV disease and has both written and presented in the US and internationally in those areas. He is currently president of the Endocrine Fellows Foundation and is actively involved in enhancing career opportunities for trainees in Endocrinology.About NACE http://naceonline.com Mission The mission of NACE is to offer continuing education opportunities to provide learners in the fields of medicine, behavioral health, education, and related disciplines, with the most up-to-date, science-based information that will enable them to increase their knowledge, skills, confidence, and professional performance to ultimately benefit the public’s health. Vision The vision for NACE is to be recognized as the leader in primary care continuing education and to be known for a comprehensive suite of programs, which are tailored to the individual needs of practitioners and which emphasize innovation, outcomes, and clinical relevance. Commitment to Compliance NACE received re-accreditation as an ACCME provider with Commendation in March 2014 and is committed to comply with the Criteria and Standards set forth by the ACCME, the ACCME’s Content Validation Value Statement, and the AMA’s Standards and Ethical Opinions to ensure that certified educational activities meet the highest standards. This educational activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.This activity is not certified for CME/CE credit.
